Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
Delayed Quote. Delayed Nyse - 09/20 04:10:00 pm
259.27 USD   -1.02%
09/08INSIDER SELL : Becton Dickinson
MT
09/08INSIDER SELL : Becton Dickinson &
MT
09/08BECTON, DICKINSON AND COMPANY : Ex-dividend day for
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

BD to Begin Remediation for BD Alaris™ System Software

07/29/2021 | 06:50am EDT

BD announced that the company will begin remediation for the February 4, 2020 BD Alaris™ System recall through a new version of software. The February 4, 2020 voluntary recall action notified customers of the following areas where the infusion pump may not operate as expected: Software errors related to System Error Code 255-XX-XXX; Delay options programming; Low Battery Alarm Failure; Keep vein open (KVO)/End of Infusion alarms priority; Use errors related to Customer Concentrations Programming. Under U.S. Food and Drug Administration guidance, BD will release Alaris™ System software version 12.1.2 and associated ancillary software to remediate the affected software. Effective customers can begin scheduling remediation by contacting the BD Recall Support Center at 1-888-562-6018. The new software, which will be available at no cost to customers, is expected to remediate the issues identified in the February 4, 2020 recall notice and provide programming, operational and cybersecurity updates to affected devices; however, this software update has not been reviewed or cleared by the FDA.


© S&P Capital IQ 2021
All news about BECTON, DICKINSON AND COMPANY
09/08INSIDER SELL : Becton Dickinson
MT
09/08INSIDER SELL : Becton Dickinson &
MT
09/08BECTON, DICKINSON AND COMPANY : Ex-dividend day for
FA
09/03BECTON DICKINSON AND : BD Celebrates 60 Years in Canaan, Conn. - Canaan Facility..
AQ
09/03INSIDER SELL : Becton Dickinson & Co
MT
09/02BECTON DICKINSON AND : BD Celebrates 60 Years in Canaan, Conn.
PU
08/30BECTON DICKINSON AND : & CO Change in Directors or Principal Officers (form 8-K/..
AQ
08/27BECTON DICKINSON AND : RPS - Supply disruption to Becton Dickinson blood specime..
AQ
08/27QUIDEL : U.S. COVID-19 tests again in short supply as infections soar, schools r..
RE
08/26BECTON DICKINSON AND : BD to Present at Two Upcoming Virtual Healthcare Investor..
PR
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2021 20 009 M - -
Net income 2021 2 231 M - -
Net Debt 2021 14 336 M - -
P/E ratio 2021 33,7x
Yield 2021 1,42%
Capitalization 74 460 M 74 460 M -
EV / Sales 2021 4,44x
EV / Sales 2022 4,46x
Nbr of Employees 72 000
Free-Float 78,2%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | BDX | US0758871091 | MarketScreener
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 259,27 $
Average target price 269,87 $
Spread / Average Target 4,09%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Chris DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY3.62%75 229
ABBOTT LABORATORIES15.80%224 776
MEDTRONIC PLC10.72%174 552
HOYA CORPORATION30.10%62 323
ALIGN TECHNOLOGY, INC.34.62%56 839
SARTORIUS STEDIM BIOTECH79.60%56 591